메뉴 건너뛰기




Volumn 150, Issue 6, 2007, Pages

Nephropathy Advancing to End-Stage Renal Disease: A Novel Complication of Lysinuric Protein Intolerance

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; BICARBONATE; CALCIUM; CARNITINE; CREATININE; CYSTATIN C; ERYTHROPOIETIN; IRON; LYSINE; PHOSPHATE; PREDNISOLONE;

EID: 34248562881     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.01.043     Document Type: Article
Times cited : (39)

References (40)
  • 1
    • 50549192830 scopus 로고
    • Protein intolerance with deficient transport of basic amino acids
    • Perheentupa J., and Visakorpi J. Protein intolerance with deficient transport of basic amino acids. Lancet 2 (1965) 813-816
    • (1965) Lancet , vol.2 , pp. 813-816
    • Perheentupa, J.1    Visakorpi, J.2
  • 2
    • 0018839583 scopus 로고
    • Basolateral-membrane transport defect for lysine in lysinuric protein intolerance
    • Rajantie J., Simell O., and Perheentupa J. Basolateral-membrane transport defect for lysine in lysinuric protein intolerance. Lancet 1 (1980) 1219-1221
    • (1980) Lancet , vol.1 , pp. 1219-1221
    • Rajantie, J.1    Simell, O.2    Perheentupa, J.3
  • 3
    • 0015167907 scopus 로고
    • Lysinuric protein intolerance, an autosomal recessive disease
    • Norio R., Kekomäki M., and Visakorpi J.K. Lysinuric protein intolerance, an autosomal recessive disease. Clin Genet (1971) 214-222
    • (1971) Clin Genet , pp. 214-222
    • Norio, R.1    Kekomäki, M.2    Visakorpi, J.K.3
  • 5
    • 0034268001 scopus 로고    scopus 로고
    • A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect
    • Koizumi A., Shoji Y., Nozaki J., Noguchi A., Dakeishi M., Ohura T., et al. A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. Hum Mutat 16 (2000) 270-271
    • (2000) Hum Mutat , vol.16 , pp. 270-271
    • Koizumi, A.1    Shoji, Y.2    Nozaki, J.3    Noguchi, A.4    Dakeishi, M.5    Ohura, T.6
  • 6
    • 0032484216 scopus 로고    scopus 로고
    • Identification and characterization of a membrane protein (y(+)L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y(+)L-a candidate gene for lysinuric protein intolerance
    • Torrents D., Estevez R., Pineda M., Fernandez E., Lloberas J., Shi Y.B., et al. Identification and characterization of a membrane protein (y(+)L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y(+)L-a candidate gene for lysinuric protein intolerance. J Biol Chem 273 (1998) 32437-32445
    • (1998) J Biol Chem , vol.273 , pp. 32437-32445
    • Torrents, D.1    Estevez, R.2    Pineda, M.3    Fernandez, E.4    Lloberas, J.5    Shi, Y.B.6
  • 7
    • 0344699322 scopus 로고    scopus 로고
    • Identification of SLC7A7, encoding y(+)LAT-1, as the lysinuric protein intolerance gene
    • Torrents D., Mykkänen J., Pineda M., Feliubadalo L., Estevez R., de Cid R., et al. Identification of SLC7A7, encoding y(+)LAT-1, as the lysinuric protein intolerance gene. Nat Genet 21 (1999) 293-296
    • (1999) Nat Genet , vol.21 , pp. 293-296
    • Torrents, D.1    Mykkänen, J.2    Pineda, M.3    Feliubadalo, L.4    Estevez, R.5    de Cid, R.6
  • 8
    • 0033017645 scopus 로고    scopus 로고
    • SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance
    • Borsani G., Bassi M.T., Sperandeo M.P., De Grandi A., Buoninconti A., Riboni M., et al. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet 21 (1999) 297-301
    • (1999) Nat Genet , vol.21 , pp. 297-301
    • Borsani, G.1    Bassi, M.T.2    Sperandeo, M.P.3    De Grandi, A.4    Buoninconti, A.5    Riboni, M.6
  • 11
    • 0028876643 scopus 로고
    • Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course
    • Parenti G., Sebastio G., Strisciuglio P., Incerti B., Pecoraro C., Terracciano L., et al. Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course. J Pediatr 126 (1995) 246-251
    • (1995) J Pediatr , vol.126 , pp. 246-251
    • Parenti, G.1    Sebastio, G.2    Strisciuglio, P.3    Incerti, B.4    Pecoraro, C.5    Terracciano, L.6
  • 12
    • 0027180730 scopus 로고
    • Role of hematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intolerance
    • DiRocco M., Garibotto G., Rossi G.A., Caruso U., Taccone A., Picco P., et al. Role of hematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intolerance. Eur J Pediatr 152 (1993) 437-440
    • (1993) Eur J Pediatr , vol.152 , pp. 437-440
    • DiRocco, M.1    Garibotto, G.2    Rossi, G.A.3    Caruso, U.4    Taccone, A.5    Picco, P.6
  • 14
    • 0028285367 scopus 로고
    • Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance-case reports and autopsy findings of 4 pediatric patients
    • Parto K., Kallajoki M., Aho H., and Simell O. Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance-case reports and autopsy findings of 4 pediatric patients. Hum Pathol 25 (1994) 400-407
    • (1994) Hum Pathol , vol.25 , pp. 400-407
    • Parto, K.1    Kallajoki, M.2    Aho, H.3    Simell, O.4
  • 16
    • 15944399931 scopus 로고    scopus 로고
    • Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes
    • Boright A.P., Paterson A.D., Mirea L., Bull S.B., Mowjoodi A., Scherer S.W., et al. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes. Diabetes 54 (2005) 1238-1244
    • (2005) Diabetes , vol.54 , pp. 1238-1244
    • Boright, A.P.1    Paterson, A.D.2    Mirea, L.3    Bull, S.B.4    Mowjoodi, A.5    Scherer, S.W.6
  • 17
    • 85058202020 scopus 로고    scopus 로고
    • Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis
    • Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. J Am Soc.Nephrol 13 (2002) 452A
    • (2002) J Am Soc.Nephrol , vol.13
    • Dharnidharka, V.R.1    Kwon, C.2    Stevens, G.3
  • 19
    • 0141507021 scopus 로고    scopus 로고
    • A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate
    • Hoek F.J., Kemperman F.A.W., and Krediet R.T. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18 (2003) 2024-2031
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 2024-2031
    • Hoek, F.J.1    Kemperman, F.A.W.2    Krediet, R.T.3
  • 20
    • 0141789624 scopus 로고    scopus 로고
    • Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition-a patient-level meta-analysis
    • Jafar T.H., Stark P.C., Schmid C.H., Landa M., Maschio G., de Jong P.E., et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition-a patient-level meta-analysis. Ann Int Med 139 (2003) 244-252
    • (2003) Ann Int Med , vol.139 , pp. 244-252
    • Jafar, T.H.1    Stark, P.C.2    Schmid, C.H.3    Landa, M.4    Maschio, G.5    de Jong, P.E.6
  • 21
    • 3042819708 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
    • [Anon]
    • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. [Anon]. Am J Kidney Dis 43 (2004) 14-290
    • (2004) Am J Kidney Dis , vol.43 , pp. 14-290
  • 22
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3    Cushman, W.C.4    Green, L.A.5    Izzo, J.L.6
  • 23
    • 0035902622 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease-a meta-analysis of patient-level data
    • Jafar T.H., Schmid C.H., Landa M., Giatras I., Toto R., Remuzzi G., et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease-a meta-analysis of patient-level data. Ann Int Med 135 (2001) 73-87
    • (2001) Ann Int Med , vol.135 , pp. 73-87
    • Jafar, T.H.1    Schmid, C.H.2    Landa, M.3    Giatras, I.4    Toto, R.5    Remuzzi, G.6
  • 24
    • 0030604561 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
    • Ruggenenti P., Perna A., Mosconi L., Matalone M., Garini G., Salvadori M., et al. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349 (1997) 1857-1863
    • (1997) Lancet , vol.349 , pp. 1857-1863
    • Ruggenenti, P.1    Perna, A.2    Mosconi, L.3    Matalone, M.4    Garini, G.5    Salvadori, M.6
  • 25
    • 30444452987 scopus 로고    scopus 로고
    • Efficacy and safety of benazepril for advanced chronic renal insufficiency
    • Hou F.F., Zhang X., Zhang G.H., Xie D., Chen P.Y., Zhang W.R., et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354 (2006) 131-140
    • (2006) N Engl J Med , vol.354 , pp. 131-140
    • Hou, F.F.1    Zhang, X.2    Zhang, G.H.3    Xie, D.4    Chen, P.Y.5    Zhang, W.R.6
  • 26
    • 33645451066 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation
    • Heinze G., Mitterbauer C., Regele H., Kramar R., Winkelmayer W.C., Curhan G.C., et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17 (2006) 889-899
    • (2006) J Am Soc Nephrol , vol.17 , pp. 889-899
    • Heinze, G.1    Mitterbauer, C.2    Regele, H.3    Kramar, R.4    Winkelmayer, W.C.5    Curhan, G.C.6
  • 27
    • 28644447771 scopus 로고    scopus 로고
    • Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients
    • Ki C.S., Kim I.S., Kim J.W., Lee N.Y., Kim S.H., Lee K.W., et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant 19 (2005) 751-755
    • (2005) Clin Transplant , vol.19 , pp. 751-755
    • Ki, C.S.1    Kim, I.S.2    Kim, J.W.3    Lee, N.Y.4    Kim, S.H.5    Lee, K.W.6
  • 28
    • 0021362187 scopus 로고
    • Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes-evidence for alterations in tissue carnitine transport
    • Rebouche C.J., and Engel A.G. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes-evidence for alterations in tissue carnitine transport. J Clin Invest 73 (1984) 857-867
    • (1984) J Clin Invest , vol.73 , pp. 857-867
    • Rebouche, C.J.1    Engel, A.G.2
  • 29
    • 0023543711 scopus 로고
    • Carnitine deficiency in lysinuric protein intolerance-lysine-sparing effect of carnitine
    • Takada G., Goto A., Komatsu K., and Goto R. Carnitine deficiency in lysinuric protein intolerance-lysine-sparing effect of carnitine. Tohoku J Exp Med 153 (1987) 331-334
    • (1987) Tohoku J Exp Med , vol.153 , pp. 331-334
    • Takada, G.1    Goto, A.2    Komatsu, K.3    Goto, R.4
  • 31
    • 0037379698 scopus 로고    scopus 로고
    • Dialysis-related carnitine disorder and levocarnitine pharmacology
    • Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 41 (2003) S13-S26
    • (2003) Am J Kidney Dis , vol.41
    • Evans, A.1
  • 32
    • 0033830243 scopus 로고    scopus 로고
    • Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis
    • Evans A.M., Faull R., Fornasini G., Lemanowicz E.F., Longo A., Pace S., et al. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 68 (2000) 238-249
    • (2000) Clin Pharmacol Ther , vol.68 , pp. 238-249
    • Evans, A.M.1    Faull, R.2    Fornasini, G.3    Lemanowicz, E.F.4    Longo, A.5    Pace, S.6
  • 34
    • 12244254419 scopus 로고    scopus 로고
    • Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder-National Kidney Foundation carnitine consensus conference
    • Eknoyan G., Latos D.L., and Lindberg J. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder-National Kidney Foundation carnitine consensus conference. Am J Kidney Dis 41 (2003) 868-876
    • (2003) Am J Kidney Dis , vol.41 , pp. 868-876
    • Eknoyan, G.1    Latos, D.L.2    Lindberg, J.3
  • 35
    • 0034803056 scopus 로고    scopus 로고
    • Prevalence and causes of low bone density and fractures in kidney transplant patients
    • Patel S., Kwan J.T.C., McCloskey E., Mcgee G., Thomas G., Johnson D., et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16 (2001) 1863-1870
    • (2001) J Bone Miner Res , vol.16 , pp. 1863-1870
    • Patel, S.1    Kwan, J.T.C.2    McCloskey, E.3    Mcgee, G.4    Thomas, G.5    Johnson, D.6
  • 37
    • 0027511141 scopus 로고
    • Skeletal manifestations of lysinuric protein intolerance-a follow-up study of 29 patients
    • Svedström E., Parto K., Marttinen M., Virtama P., and Simell O. Skeletal manifestations of lysinuric protein intolerance-a follow-up study of 29 patients. Skeletal Radiol 22 (1993) 11-16
    • (1993) Skeletal Radiol , vol.22 , pp. 11-16
    • Svedström, E.1    Parto, K.2    Marttinen, M.3    Virtama, P.4    Simell, O.5
  • 39
    • 0031733360 scopus 로고    scopus 로고
    • Hyperlipidemia in patients with chronic renal disease
    • Kasiske B.L. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32 (1998) S142-S156
    • (1998) Am J Kidney Dis , vol.32
    • Kasiske, B.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.